ML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageRivaroxaban is an oxazolidinone derivative optimized for inhibiting both free Factor Xa and Factor Xa bound in the prothrombinase complex.
More Information Supplier PageRivaroxaban is an oxazolidinone derivative optimized for inhibiting both free Factor Xa and Factor Xa bound in the prothrombinase complex.
More Information Supplier PageBP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
More Information Supplier PageGW6471 is a PPAR?? antagonist, shown to completely inhibit GW409544-induced activation of PPAR??.
More Information Supplier PageGW6471 is a PPAR?? antagonist, shown to completely inhibit GW409544-induced activation of PPAR??.
More Information Supplier PageGW6471 is a PPAR?? antagonist, shown to completely inhibit GW409544-induced activation of PPAR??.
More Information Supplier PageGW6471 is a PPAR?? antagonist, shown to completely inhibit GW409544-induced activation of PPAR??.
More Information Supplier Page
